M-type pyruvate kinase 2 (PKM2) tetramerization alleviates the progression of right ventricle failure by regulating oxidative stress and mitochondrial dynamics.
M-type pyruvate kinase 2 (PKM2) tetramerization alleviates the progression of right ventricle failure by regulating oxidative stress and mitochondrial dynamics.
复制标题
DOI:
10.1186/s12967-023-04780-6
复制
发表时间:
2023-12-07
影响因子:
7.4
通讯作者:
Wang E
中科院分区:
文献类型:
--
作者:
Guo L;Wang L;Qin G;Zhang J;Peng J;Li L;Chen X;Wang D;Qiu J;Wang E
Right ventricle failure (RVF) is a progressive heart disease that has yet to be fully understood at the molecular level. Elevated M-type pyruvate kinase 2 (PKM2) tetramerization alleviates heart failure, but detailed molecular mechanisms remain unclear. We observed changes in PKM2 tetramerization levels during the progression of right heart failure and in vitro cardiomyocyte hypertrophy and explored the causal relationship between altered PKM2 tetramerization and the imbalance of redox homeostasis in cardiomyocytes, as well as its underlying mechanisms. Ultimately, our goal was to propose rational intervention strategies for the treatment of RVF. We established RVF in Sprague Dawley (SD) rats by intraperitoneal injection of monocrotaline (MCT). The pulmonary artery pressure and right heart function of rats were assessed using transthoracic echocardiography combined with right heart catheterization. TEPP-46 was used both in vivo and in vitro to promote PKM2 tetramerization. We observed that oxidative stress and mitochondrial disorganization were associated with increased apoptosis in the right ventricular tissue of RVF rats. Quantitative proteomics revealed that PKM2 was upregulated during RVF and negatively correlated with the cardiac function. Facilitating PKM2 tetramerization promoted mitochondrial network formation and alleviated oxidative stress and apoptosis during cardiomyocyte hypertrophy. Moreover, enhancing PKM2 tetramer formation improved cardiac mitochondrial morphology, mitigated oxidative stress and alleviated heart failure. Disruption of PKM2 tetramerization contributed to RVF by inducing mitochondrial fragmentation, accumulating ROS, and finally promoted the progression of cardiomyocyte apoptosis. Facilitating PKM2 tetramerization holds potential as a promising therapeutic approach for RVF. The online version contains supplementary material available at 10.1186/s12967-023-04780-6.
登录
查看更多内容
影响因子:
20.1
作者:
Carlson CR;Aronsen JM;Bergan-Dahl A;Moutty MC;Lunde M;Lunde PK;Jarstadmarken H;Wanichawan P;Pereira L;Kolstad TRS;Dalhus B;Subramanian H;Hille S;Christensen G;Müller OJ;Nikolaev V;Bers DM;Sjaastad I;Shen X;Louch WE;Klussmann E;Sejersted OM
通讯作者:
Sejersted OM
DOI:
10.1126/science.1211485
发表时间:
2011-12-02
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Anastasiou D;Poulogiannis G;Asara JM;Boxer MB;Jiang JK;Shen M;Bellinger G;Sasaki AT;Locasale JW;Auld DS;Thomas CJ;Vander Heiden MG;Cantley LC
通讯作者:
Cantley LC
影响因子:
11.2
作者:
Apostolidi M;Vathiotis IA;Muthusamy V;Gaule P;Gassaway BM;Rimm DL;Rinehart J
通讯作者:
Rinehart J
影响因子:
13.6
作者:
通讯作者:
--
影响因子:
44.1
作者:
Liang J;Cao R;Wang X;Zhang Y;Wang P;Gao H;Li C;Yang F;Zeng R;Wei P;Li D;Li W;Yang W
通讯作者:
Yang W